Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Hero

Showing results (61-70 of 141) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcomeMatthias Fischer, André Oberthuer, Benedikt Brors, et al.
Pediatric Blood & Cancer|August 3, 2023
Image-defined risk factors in localized thoracic neuroblastoma and ganglioneuromaSarina K Butzer, Barbara Krug, Maike Reisberg, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 10, 2020
Long-term follow-up of children with neuroblastoma receiving radiotherapy to metastatic lesions within the German Neuroblastoma Trials NB97 and NB 2004Danny Jazmati, Sarina Butzer, Barbara Hero, et al.
Cancer Letters|November 28, 2006
Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified diseaseAndré Oberthuer, Patrick Warnat, Yvonne Kahlert, et al.
BMC Cancer|November 20, 2014
FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastomaSandra Ackermann, Hayriye Kocak, Barbara Hero, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 2003
Evidence for hypoxia-induced neuronal-to-chromaffin metaplasia in neuroblastomaFredrik Hedborg, Erik Ullerås, Lars Grimelius, et al.
Biomedical Reports|July 15, 2015
Absence of telomerase reverse transcriptase promoter mutations in neuroblastomaSven Lindner, Hagen S Bachmann, Andrea Odersky, et al.
Pediatric Blood & Cancer|May 31, 2020
The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) projectVeronica Moroz, David Machin, Barbara Hero, et al.
BMC Cancer|July 29, 2016
Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixedBoris Decarolis, Thorsten Simon, Barbara Krug, et al.
Cancers|September 10, 2021
Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by <i>MYCN</i> AmplificationFrank Berthold, Angela Ernst, Sandra Ackermann, et al.
Pageof 15

Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcomeMatthias Fischer, André Oberthuer, Benedikt Brors, et al.
Pediatric Blood & Cancer|August 3, 2023
Image-defined risk factors in localized thoracic neuroblastoma and ganglioneuromaSarina K Butzer, Barbara Krug, Maike Reisberg, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 10, 2020
Long-term follow-up of children with neuroblastoma receiving radiotherapy to metastatic lesions within the German Neuroblastoma Trials NB97 and NB 2004Danny Jazmati, Sarina Butzer, Barbara Hero, et al.
Cancer Letters|November 28, 2006
Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified diseaseAndré Oberthuer, Patrick Warnat, Yvonne Kahlert, et al.
BMC Cancer|November 20, 2014
FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastomaSandra Ackermann, Hayriye Kocak, Barbara Hero, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 2003
Evidence for hypoxia-induced neuronal-to-chromaffin metaplasia in neuroblastomaFredrik Hedborg, Erik Ullerås, Lars Grimelius, et al.
Biomedical Reports|July 15, 2015
Absence of telomerase reverse transcriptase promoter mutations in neuroblastomaSven Lindner, Hagen S Bachmann, Andrea Odersky, et al.
Pediatric Blood & Cancer|May 31, 2020
The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) projectVeronica Moroz, David Machin, Barbara Hero, et al.
BMC Cancer|July 29, 2016
Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixedBoris Decarolis, Thorsten Simon, Barbara Krug, et al.
Cancers|September 10, 2021
Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by <i>MYCN</i> AmplificationFrank Berthold, Angela Ernst, Sandra Ackermann, et al.
Pageof 15